Cumberland Pharmaceuticals (CPIX.US) will release its Earnings Reports after the market closes on March 4.

$ Cumberland Pharmaceuticals (CPIX.US) $ will release its Earnings Reports after the market closes on March 4th, investors please pay attention. How was the previous performance? $ Cumberland Pharmaceuticals (CPIX.US) $ 2024 Q3 revenue is 9.0858 million USD, Net income is -1.537 million USD, EPS is -0.11 USD. 2023 Q4 revenue is 9.3531 million USD, Net income is -6.302 million USD, EPS is -0.44 USD. The accounting standards used for the above data are US_GAAP. Futubull reminds: 1. The accounting year division time for Hong Kong and US listed companies.

Moomoo News20:00 ET

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2024 FINANCIAL RESULTS

PR NewswireFeb 25 16:05 ET

Express News | Cumberland Pharmaceuticals Inc -Vibativ Receives Marketing Approval in China

ReutersFeb 18 07:33 ET

Express News | Cumberland Pharmaceuticals Inc - Increases Max Aggregate Shares Offering Price to $10 Million

ReutersFeb 14 16:29 ET

Cumberland Pharma (CPIX) Achieves Key Milestone, Stock Jumps

Stocks TelegraphFeb 5 13:33 ET

Express News | Cumberland Pharmaceuticals Shares Halted On Circuit Breaker To The Downside, Stock Now Up 38.3%

BenzingaFeb 5 10:09 ET